SCILEX HOLDING COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.090 USD | -5.22% |
|
+6.86% | -46.57% |
| 09-12 | Scilex Gets Drug Distributor Accreditation from National Association of Boards of Pharmacy | MT |
| 09-03 | Scilex Unit Semnur Pharmaceuticals, Denali Capital Sign Merger Agreement | MT |
EPS & Dividend: Scilex Holding Company
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.17 | -1.28 | -1.19 | -0.4467 | -0.445 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 3.990 | 2.040 | 1.090 | 1.090 | 1.090 |
| Nbr of stocks (in thousands) | 141,349 | 97,837 | 131,722 | - | - |
| Announcement Date | 23-03-07 | 24-03-12 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Scilex Holding Company
| 2024-11-16 10:30 | American College of Rheumatology Convergence Conference |
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +1.37% | +1.53% | 24.46x | 2.534 | 3.74x | ||
| +1.79% | +1.88% | 25.17x | 2.018 | 2.83x | ||
| +0.33% | +0.34% | 62.44x | 4.505 | 4.51x | ||
| -.--% | -.--% | 114.59x | 22.66 | 15.22x | ||
| +0.66% | +0.99% | 33.86x | 2.860 | 6.09x | ||
| +17.86% | +20.34% | 11.2x | 1.041 | - | ||
| - | - | 27.95x | 5.861 | - | ||
| - | - | 107.28x | - | - | ||
| - | - | - | - | - | ||
| Average | +3.67% | +4.18% | 50.87x | 5.93 | 6.48x | |
| Weighted average by Cap. | +1.54% | +1.72% | 33.01x | 3.74 | 4.39x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition